Early antipsychotic non-response as a predictor of non-response and non-remission in adolescents with psychosis treated with aripiprazole or quetiapine: results from the tea trial

Home Early antipsychotic non-response as a predictor of non-response and non-remission in adolescents with psychosis treated with aripiprazole or quetiapine: results from the tea trial

<strong>Early antipsychotic non-response as a predictor of non-response and non-remission in adolescents with psychosis treated with aripiprazole or quetiapine: results from the tea trial</strong>

Early antipsychotic non-response as a predictor of non-response and non-remission in adolescents with psychosis treated with aripiprazole or quetiapine: results from the tea trial

Feb 4, 2022 | Posted by ICAMH.org@gmail.com |

The PANNS-6 can be used to gauge early response from antipsychotics such as aripipriazole and quetiapine and accelerate change to alternative forms of medication.

Pagsberg, A. K., Krogmann, A., Jeppesen, P., von Hardenberg, L., Klauber, D. G., Jensen, K. G., … & Galling, B. (2022). Early Antipsychotic Non-response as a Predictor of Non-response and Non-remission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial. Journal of the American Academy of Child & Adolescent Psychiatry.

https://www.jaacap.org/article/S0890-8567(22)00001-6/fulltext?dgcid=raven_jbs_aip_email

Back

Early antipsychotic non-response as a predictor of non-response and non-remission in adolescents with psychosis treated with aripiprazole or quetiapine: results from the tea trial

Early antipsychotic non-response as a predictor of non-response and non-remission in adolescents with psychosis treated with aripiprazole or quetiapine: results from the tea trial

Find us on